Fenbendazole & Cancer
Subscribe
Sign in
Home
Notes
Fenbendazole Newsletter
Archive
Leaderboard
About
Latest
Top
Discussions
Comprehensive Clinical Evidence Synthesis Report: Efficacy, Preclinical Mechanisms, and Safety Profile of Curcumin Formulations
Modern cellular and clinical evaluations confirm that curcumin is a natural compound exhibiting a broad multi-target therapeutic profile.
19 hrs ago
•
Fenbendazole & Cancer
6
1
Curcumin and Cancer
Curcuminoids demonstrate broad multi-targeted activity across several pathways crucial to cancer development.
19 hrs ago
•
Fenbendazole & Cancer
7
2
1
Supplement Information: Turmeric, Curcumin and Cancer
Miracle cure or myth?
19 hrs ago
•
Fenbendazole & Cancer
12
2
Niclosamide and Cancer: Research and Clinical Trials
Three cancer trials are currently active on ClinicalTrials.gov
Oct 20
•
Fenbendazole & Cancer
1
Niclosamide Synergy
Reader requested: Niclosamide. This article discusses in vitro and in vivo preclinical testing (Lab & Animal).
Oct 19
•
Fenbendazole & Cancer
7
1
Fenbendazole Oncology Case Comparison
Comparing the Diffuse Large B-Cell Lymphoma (DLBCL) case report with the three solid tumor cases (breast, prostate, and melanoma)
Oct 19
•
Fenbendazole & Cancer
8
2
Small Bowel NET: Appointment Guide
Downloadable PDF file. Includes list of source documents. Reader requested.
Oct 19
•
Fenbendazole & Cancer
5
1
Niclosamide Prodrugs
Prodrugs overcome bioavailability through several chemical and pharmacokinetic enhancements. Reader requested.
Oct 19
•
Fenbendazole & Cancer
8
1
3
Fenbendazole Tubulin Binding [highly technical]
Docking scores let researchers rank compounds by how well they fit the active site relative to a known reference drug.
Oct 19
•
Fenbendazole & Cancer
6
2
Changes to Our Substack Format Beginning November 1, 2026
Oct 19
•
Fenbendazole & Cancer
6
Comparative Metabolic Disruption and Synergistic Profiling of Fenbendazole (FBZ) in Cancer Models
Preclinical studies and real-world case reports suggest that Fenbendazole represents an intriguing candidate for drug repurposing in oncology.
Oct 18
•
Fenbendazole & Cancer
6
2
Fenbendazole Lymphoma Case
An elderly patient who achieved significant disease regression after self-administering Fenbendazole.
Oct 18
•
Fenbendazole & Cancer
7
4
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts